Your browser doesn't support javascript.
loading
Drug Manufacturers' Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug Administration.
Ma, Paul; Marinovic, Iván; Karaca-Mandic, Pinar.
Affiliation
  • Ma P; Carlson School of Management, University of Minnesota, Minneapolis.
  • Marinovic I; Graduate School of Business, Stanford University, Palo Alto, California.
  • Karaca-Mandic P; Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis4National Bureau of Economic Research, Cambridge, Massachusetts.
JAMA Intern Med ; 175(9): 1565-6, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26214395
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adverse Drug Reaction Reporting Systems / Disclosure / Drug-Related Side Effects and Adverse Reactions Limits: Humans Country/Region as subject: America do norte Language: En Journal: JAMA Intern Med Year: 2015 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adverse Drug Reaction Reporting Systems / Disclosure / Drug-Related Side Effects and Adverse Reactions Limits: Humans Country/Region as subject: America do norte Language: En Journal: JAMA Intern Med Year: 2015 Document type: Article Country of publication: United States